403 Error
Sorry, the page you have requested
may have been moved or deleted.
Sorry, the page you have requested
may have been moved or deleted.
VITRAKVI is a prescription medicine that is used to treat adults and children with solid tumors (cancer) that:
Your healthcare provider will perform a test to make sure that VITRAKVI is right for you.
NTRK, neurotrophic receptor tyrosine kinase; TRK, tropomyosin receptor kinase.
VITRAKVI may cause serious side effects, including:
Your healthcare provider may decrease your dose, temporarily stop or permanently stop your treatment with VITRAKVI if you develop serious side effects.
Before taking VITRAKVI, tell your healthcare provider about all of your medical conditions, including if you:
are pregnant or plan to become pregnant. VITRAKVI can harm your unborn baby. Tell your healthcare provider right away if you become pregnant during treatment with VITRAKVI or think you may be pregnant.
Females who are able to become pregnant:
Males with female partners who are able to become pregnant:
While on VITRAKVI, you should avoid:
Tell your healthcare provider about all of the medicines you take, including prescription and over the counter (OTC) medicines, vitamins, and herbal supplements. Taking VITRAKVI with certain other medicines may affect the amount of VITRAKVI or other medicines in your blood and may cause side effects or affect the way that VITRAKVI works.
The most common side effects with VITRAKVI include:
VITRAKVI may affect fertility in females and may affect your ability to become pregnant. Talk to your healthcare provider if this is a concern for you.
These are not all the possible side effects with VITRAKVI. Call your healthcare provider for medical advice about side effects. You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088.
VITRAKVI is a prescription medicine that is used to treat adults and children with solid tumors (cancer) that:
Your healthcare provider will perform a test to make sure that VITRAKVI is right for you.
NTRK, neurotrophic receptor tyrosine kinase; TRK, tropomyosin receptor kinase.
For important risk and use information about VITRAKVI, please see the full Prescribing Information.
For Bayer products, you can report these directly to Bayer by clicking here.
© 2025 Bayer. Bayer, the Bayer Cross, and VITRAKVI are registered trademarks of Bayer, and TRAK Assist and VITRAKVI Commitment Program are trademarks of Bayer. All other trademarks are the property of their respective owners.
This site is intended for US audiences only.
Last updated on 06/2025